MPM BIOVENTURES III-QP L.P. [Rocket]

Date Filed	Type	Description
08/30/2018	SC 13D/A	MPM BIOVENTURES III-QP L.P. reports a 0% stake in RADIUS HEALTH, INC.
10/03/2016	SC 13D/A	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
02/05/2015	SC 13G/A	MPM BIOVENTURES III-QP L.P. reports a 2.6% stake in Portola Pharmaceuticals, Inc.
02/12/2014	SC 13G	MPM BIOVENTURES III-QP L.P. reports a 6.2% stake in Portola Pharmaceuticals, Inc.
05/07/2013	SC 13D/A	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
10/02/2012	SC 13D/A	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
07/20/2012	SC 13D/A	Form SC 13D - General statement of acquisition of beneficial ownership [amend]
06/12/2012	SC 13D/A	Form SC 13D - General statement of acquisition of beneficial ownership [amend]
12/27/2011	SC 13D/A	Form SC 13D - General statement of acquisition of beneficial ownership [amend]
10/31/2011	SC 13D/A	Form SC 13D - General statement of acquisition of beneficial ownership [amend]
10/14/2011	SC 13D/A	Form SC 13D - General statement of acquisition of beneficial ownership [amend]
05/27/2011	SC 13D	Form SC 13D - General statement of acquisition of beneficial ownership
12/23/2010	SC 13D/A	Form SC 13D - General statement of acquisition of beneficial ownership [amend]
10/13/2010	SC 13D/A	Form SC 13D - General statement of acquisition of beneficial ownership [amend]
03/17/2010	SC 13D/A	Form SC 13D - General statement of acquisition of beneficial ownership [amend]
01/05/2010	SC 13D	Form SC 13D - General statement of acquisition of beneficial ownership
07/16/2009	SC 13D	MPM BIOVENTURES III QP LP has filed a Schedule 13D for Somaxon Pharmaceuticals, Inc.
03/04/2009	SC 13D	Form SC 13D -- General statement of acquisition of beneficial ownership